RBM5 and acute myeloid leukemia: Two independent shRNAs (RBM5: sh#1 and sh#2) had been validated to efficiently suppress RBM5 expression in three validated AML cell lines and significantly impaired cell growth and reduced colony numbers (Fig. 3a–c).